News

The patent covers three main ways of associating the nanoparticles with filter media – having pellets of nanoparticles located adjacent to the filter media, coating the filter media

Sinobiomed will conduct the trial in collaboration with Mahidol University in Bangkok, Thailand. The study site is located in Thailand’s Ratchaburi Province, approximately 200km from Bangkok near the

T Baugh III, managing director of Bourne Partners, has been named CEO of Theramed. Concurrent with the acquisition of Theramed, Bourne Partners has assigned its exclusive right to

The trial is designed to assess the safety and pharmacokinetics of a single intravenous infusion of recombinant human plasma gelsolin (rhu-pGSN) in critically ill patients with profound hypogelsolinemia

The agreement includes an exclusive license to data from a planned study intended to provide long-term follow-up on the hearing status, disease-free status and overall survival of patients

The FDA approved Treximet for the acute treatment of migraine attacks, with or without aura, in adults on April 15, 2008. Treximet will be commercialized by GlaxoSmithKline.

Noninvasive total hemoglobin will be offered as part of the upgradable Masimo Rainbow SET technology platform. The Masimo Rainbow SET platform allows clinicians to noninvasively and continuously measure

The lawsuit is in response to an abbreviated new drug application filed by Novel with the FDA regarding Novel’s intent to market a generic version of Moviprep in

The study is designed to determine whether Agilus is superior to saline-control in reducing the debilitating pain associated with ankle osteoarthritis (ankle OA). If Agilus is proven to